LabCorp Extends Offer for Monogram; Aims to Settle with Shareholders | GenomeWeb

NEW YORK (GenomeWeb News) – Laboratory Corporation of America has extended until the end of the day on Aug. 3 its previously announced cash tender offer to acquire all of the outstanding shares of common stock of Monogram Biosciences.

LabCorp announced its intention to acquire Monogram for $107 million last month, and the tender offer was set to expire at the end of the day on July 29.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."